Maternal SARS-CoV-2 Vaccination and Infant Protection Against SARS-CoV-2 During the First 6 Months of Life
暂无分享,去创建一个
E. Lewis | B. Fireman | G. Ray | N. Klein | M. Greenberg | K. Goddard | O. Zerbo | Pat Ross | Kristin Goddard | Evan Layefsky | S. Omer | Ousseny Zerbo
[1] M. Stockwell,et al. Estimation of COVID-19 mRNA Vaccine Effectiveness Against Medically Attended COVID-19 in Pregnancy During Periods of Delta and Omicron Variant Predominance in the United States , 2022, JAMA network open.
[2] P. Austin,et al. Estimated Effectiveness of COVID-19 Vaccines Against Omicron or Delta Symptomatic Infection and Severe Outcomes , 2022, JAMA network open.
[3] M. Hernán,et al. BNT162b2 Vaccine Effectiveness against Omicron in Children 5 to 11 Years of Age , 2022, The New England journal of medicine.
[4] A. Randolph,et al. Maternal Vaccination and Risk of Hospitalization for Covid-19 among Infants , 2022, The New England journal of medicine.
[5] J. Kinge,et al. Association of COVID-19 Vaccination During Pregnancy With Incidence of SARS-CoV-2 Infection in Infants , 2022, JAMA internal medicine.
[6] W. Schaffner,et al. Hospitalization of Infants and Children Aged 0–4 Years with Laboratory-Confirmed COVID-19 — COVID-NET, 14 States, March 2020–February 2022 , 2022, MMWR. Morbidity and mortality weekly report.
[7] S. Gharbia,et al. Covid-19 Vaccine Effectiveness against the Omicron (B.1.1.529) Variant , 2022, The New England journal of medicine.
[8] William F. Fadel,et al. Waning 2-Dose and 3-Dose Effectiveness of mRNA Vaccines Against COVID-19–Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance — VISION Network, 10 States, August 2021–January 2022 , 2022, MMWR. Morbidity and mortality weekly report.
[9] G. Alter,et al. Durability of Anti-Spike Antibodies in Infants After Maternal COVID-19 Vaccination or Natural Infection. , 2022, JAMA.
[10] Manish M Patel,et al. Frequency, Characteristics and Complications of COVID-19 in Hospitalized Infants , 2021, The Pediatric infectious disease journal.
[11] William F. Fadel,et al. Effectiveness of Covid-19 Vaccines in Ambulatory and Inpatient Care Settings , 2021, The New England journal of medicine.
[12] M. Hernán,et al. BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting , 2021, The New England journal of medicine.
[13] S. Dominguez,et al. Risk Factors for Severe COVID-19 in Children. , 2021, The Pediatric infectious disease journal.
[14] B. Fireman,et al. Vaccine effectiveness of cell-culture relative to egg-based inactivated influenza vaccine during the 2017-18 influenza season , 2020, PloS one.
[15] A. Pollard,et al. Prevalence and decay of maternal pneumococcal and meningococcal antibodies: A meta-analysis of type-specific decay rates , 2017, Vaccine.
[16] E. Lewis,et al. Effectiveness of Vaccination During Pregnancy to Prevent Infant Pertussis , 2017, Pediatrics.